{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:26:59Z","timestamp":1793384819888,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>As a clinical manifestations of diabetic retinopathy (DR), pericytes (PCs) loss from the capillary walls is thought to be an initial pathological change responsible for the breakdown of the blood-retinal barrier (BRB). This study was performed to investigate the effects of ursodeoxycholic acid (UDCA) in PC depletion mice by injection of an antibody against platelet-derived growth factor reception-\u03b2 (PDGFR-\u03b2 clone APB5). To assess the integrity of the retinal vessels, their density, diameters, vessel branching points, and number of acellular capillaries were evaluated. While all types of retinal vessels became enlarged in APB5-induced mice, treatment with UDCA rescued the vasculature; the vessel density, diameter of the veins and capillaries, and vessel branching points were significantly lower in mice treated with UDCA. Although APB5-induced mice displayed progressive exacerbation of retinal edema, whole retinal thickness upon treatment with UDCA was significantly decreased. Additionally, UDCA reduced the expression of F4\/80<jats:sup>+<\/jats:sup> macrophages in the APB5-induced retina according to immunofluorescent labeling. UDCA also reduced the increased expression of angiogenic factors and inflammatory mediators (vascular endothelial growth factor, intercellular adhesion molecule-1, and monocyte chemotactic protein-1). These findings suggest that UDCA can be used to prevent the progression of and treat DR.<\/jats:p>","DOI":"10.1038\/s41598-020-58039-x","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T11:04:44Z","timestamp":1579691084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Ursodeoxycholic Acid Attenuates the Retinal Vascular Abnormalities in Anti-PDGFR-\u03b2 Antibody-Induced Pericyte Depletion Mouse Models"],"prefix":"10.1038","volume":"10","author":[{"given":"Tomoyasu","family":"Shiraya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiyuki","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisako","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohito","family":"Totsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5574-5470","authenticated-orcid":false,"given":"Akiyoshi","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoji","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"key":"58039_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/dme.12119","volume":"30","author":"LM Ruta","year":"2013","unstructured":"Ruta, L. M. et al. Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries. Diabet. Med. 30, 387\u2013398, https:\/\/doi.org\/10.1111\/dme.12119 (2013).","journal-title":"Diabet. Med."},{"key":"58039_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1001288","volume":"363","author":"AS Group","year":"2010","unstructured":"Group, A. S. et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. N. Engl. J. Med. 363, 233\u2013244, https:\/\/doi.org\/10.1056\/NEJMoa1001288 (2010).","journal-title":"N. Engl. J. Med."},{"key":"58039_CR3","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau, J. W. et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35, 556\u2013564, https:\/\/doi.org\/10.2337\/dc11-1909 (2012).","journal-title":"Diabetes Care"},{"key":"58039_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/CS20120588","volume":"125","author":"AW Stitt","year":"2013","unstructured":"Stitt, A. W., Lois, N., Medina, R. J., Adamson, P. & Curtis, T. M. Advances in our understanding of diabetic retinopathy. Clin. Sci. 125, 1\u201317, https:\/\/doi.org\/10.1042\/CS20120588 (2013).","journal-title":"Clin. Sci."},{"key":"58039_CR5","unstructured":"Resnikoff, S. et al. Global data on visual impairment in the year 2002. Bull World Health Organ 82, 844\u2013851, S0042-96862004001100009 (2004)."},{"key":"58039_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","volume":"21","author":"A Armulik","year":"2011","unstructured":"Armulik, A., Genove, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 21, 193\u2013215, https:\/\/doi.org\/10.1016\/j.devcel.2011.07.001 (2011).","journal-title":"Dev. Cell"},{"key":"58039_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1001\/archopht.1961.00960010368014","volume":"66","author":"DG Cogan","year":"1961","unstructured":"Cogan, D. G., Toussaint, D. & Kuwabara, T. Retinal vascular patterns. IV. Diabetic retinopathy. Arch. Ophthalmol. 66, 366\u2013378 (1961).","journal-title":"Arch. Ophthalmol."},{"key":"58039_CR8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2174\/157339910793360815","volume":"6","author":"A Praidou","year":"2010","unstructured":"Praidou, A. et al. Angiogenic growth factors and their inhibitors in diabetic retinopathy. Curr. Diabetes Rev. 6, 304\u2013312 (2010).","journal-title":"Curr. Diabetes Rev."},{"key":"58039_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.exer.2007.10.013","volume":"86","author":"R Motiejunaite","year":"2008","unstructured":"Motiejunaite, R. & Kazlauskas, A. Pericytes and ocular diseases. Exp. Eye Res. 86, 171\u2013177, https:\/\/doi.org\/10.1016\/j.exer.2007.10.013 (2008).","journal-title":"Exp. Eye Res."},{"key":"58039_CR10","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMra1005073","volume":"366","author":"DA Antonetti","year":"2012","unstructured":"Antonetti, D. A., Klein, R. & Gardner, T. W. Diabetic retinopathy. N. Engl. J. Med. 366, 1227\u20131239, https:\/\/doi.org\/10.1056\/NEJMra1005073 (2012).","journal-title":"N. Engl. J. Med."},{"key":"58039_CR11","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1016\/j.ophtha.2012.08.022","volume":"119","author":"N Diabetic Retinopathy Clinical Resea","year":"2012","unstructured":"Diabetic Retinopathy Clinical Research, N. et al. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmol. 119, 2312\u20132318, https:\/\/doi.org\/10.1016\/j.ophtha.2012.08.022 (2012).","journal-title":"Ophthalmol."},{"key":"58039_CR12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ophtha.2011.01.031","volume":"118","author":"P Mitchell","year":"2011","unstructured":"Mitchell, P. et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmol. 118, 615\u2013625, https:\/\/doi.org\/10.1016\/j.ophtha.2011.01.031 (2011).","journal-title":"Ophthalmol."},{"key":"58039_CR13","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1016\/j.ophtha.2014.05.006","volume":"121","author":"JF Korobelnik","year":"2014","unstructured":"Korobelnik, J. F. et al. Intravitreal aflibercept for diabetic macular edema. Ophthalmol. 121, 2247\u20132254, https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.006 (2014).","journal-title":"Ophthalmol."},{"key":"58039_CR14","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ophtha.2010.02.031","volume":"117","author":"N Diabetic Retinopathy Clinical Resea","year":"2010","unstructured":"Diabetic Retinopathy Clinical Research, N. et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmol. 117, 1064\u20131077 e1035, https:\/\/doi.org\/10.1016\/j.ophtha.2010.02.031 (2010).","journal-title":"Ophthalmol."},{"key":"58039_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.dld.2010.03.015","volume":"42","author":"L Maillette de Buy Wenniger","year":"2010","unstructured":"Maillette de Buy Wenniger, L. & Beuers, U. Bile salts and cholestasis. Dig. Liver Dis. 42, 409\u2013418, https:\/\/doi.org\/10.1016\/j.dld.2010.03.015 (2010).","journal-title":"Dig. Liver Dis."},{"key":"58039_CR16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.intimp.2012.11.017","volume":"15","author":"P Martinez-Moya","year":"2013","unstructured":"Martinez-Moya, P. et al. Dose-dependent antiinflammatory effect of ursodeoxycholic acid in experimental colitis. Int. Immunopharmacol. 15, 372\u2013380, https:\/\/doi.org\/10.1016\/j.intimp.2012.11.017 (2013).","journal-title":"Int. Immunopharmacol."},{"key":"58039_CR17","doi-asserted-by":"publisher","first-page":"G550","DOI":"10.1152\/ajpgi.00256.2016","volume":"312","author":"JBJ Ward","year":"2017","unstructured":"Ward, J. B. J. et al. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon. Am. J. Physiol. Gastrointest. Liver Physiol 312, G550\u2013G558, https:\/\/doi.org\/10.1152\/ajpgi.00256.2016 (2017).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol"},{"key":"58039_CR18","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1111\/all.12019","volume":"67","author":"MA Willart","year":"2012","unstructured":"Willart, M. A. et al. Ursodeoxycholic acid suppresses eosinophilic airway inflammation by inhibiting the function of dendritic cells through the nuclear farnesoid X receptor. Allergy 67, 1501\u20131510, https:\/\/doi.org\/10.1111\/all.12019 (2012).","journal-title":"Allergy"},{"key":"58039_CR19","doi-asserted-by":"publisher","first-page":"e0180673","DOI":"10.1371\/journal.pone.0180673","volume":"12","author":"WK Ko","year":"2017","unstructured":"Ko, W. K. et al. Anti-inflammatory effects of ursodeoxycholic acid by lipopolysaccharide-stimulated inflammatory responses in RAW 264.7 macrophages. PLoS One 12, e0180673, https:\/\/doi.org\/10.1371\/journal.pone.0180673 (2017).","journal-title":"PLoS One"},{"key":"58039_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejphar.2018.09.027","volume":"840","author":"H Ouyang","year":"2018","unstructured":"Ouyang, H., Mei, X., Zhang, T., Lu, B. & Ji, L. Ursodeoxycholic acid ameliorates diabetic retinopathy via reducing retinal inflammation and reversing the breakdown of blood-retinal barrier. Eur. J. Pharmacol. 840, 20\u201327, https:\/\/doi.org\/10.1016\/j.ejphar.2018.09.027 (2018).","journal-title":"Eur. J. Pharmacol."},{"key":"58039_CR21","doi-asserted-by":"publisher","first-page":"1763292","DOI":"10.1155\/2017\/1763292","volume":"2017","author":"YR Chung","year":"2017","unstructured":"Chung, Y. R., Choi, J. A., Koh, J. Y. & Yoon, Y. H. Ursodeoxycholic Acid Attenuates Endoplasmic Reticulum Stress-Related Retinal Pericyte Loss in Streptozotocin-Induced Diabetic Mice. J. Diabetes Res. 2017, 1763292, https:\/\/doi.org\/10.1155\/2017\/1763292 (2017).","journal-title":"J. Diabetes Res."},{"key":"58039_CR22","doi-asserted-by":"publisher","first-page":"e90905","DOI":"10.1172\/jci.insight.90905","volume":"2","author":"S Ogura","year":"2017","unstructured":"Ogura, S. et al. Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown. JCI Insight 2, e90905, https:\/\/doi.org\/10.1172\/jci.insight.90905 (2017).","journal-title":"JCI Insight"},{"key":"58039_CR23","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1172\/JCI15621","volume":"110","author":"A Uemura","year":"2002","unstructured":"Uemura, A. et al. Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J. Clin. Invest. 110, 1619\u20131628, https:\/\/doi.org\/10.1172\/JCI15621 (2002).","journal-title":"J. Clin. Invest."},{"key":"58039_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.001","volume":"63","author":"S Selvam","year":"2018","unstructured":"Selvam, S., Kumar, T. & Fruttiger, M. Retinal vasculature development in health and disease. Prog. Retin. Eye Res. 63, 1\u201319, https:\/\/doi.org\/10.1016\/j.preteyeres.2017.11.001 (2018).","journal-title":"Prog. Retin. Eye Res."},{"key":"58039_CR25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.yexcr.2005.10.030","volume":"312","author":"A Uemura","year":"2006","unstructured":"Uemura, A., Kusuhara, S., Katsuta, H. & Nishikawa, S. Angiogenesis in the mouse retina: a model system for experimental manipulation. Exp. Cell Res. 312, 676\u2013683, https:\/\/doi.org\/10.1016\/j.yexcr.2005.10.030 (2006).","journal-title":"Exp. Cell Res."},{"key":"58039_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2217\/imt.11.24","volume":"3","author":"W Zhang","year":"2011","unstructured":"Zhang, W., Liu, H., Rojas, M., Caldwell, R. W. & Caldwell, R. B. Anti-inflammatory therapy for diabetic retinopathy. Immunotherapy 3, 609\u2013628, https:\/\/doi.org\/10.2217\/imt.11.24 (2011).","journal-title":"Immunotherapy"},{"key":"58039_CR27","doi-asserted-by":"publisher","first-page":"213130","DOI":"10.1155\/2013\/213130","volume":"2013","author":"S Kastelan","year":"2013","unstructured":"Kastelan, S., Tomic, M., Gverovic Antunica, A., Salopek Rabatic, J. & Ljubic, S. Inflammation and pharmacological treatment in diabetic retinopathy. Mediators Inflamm. 2013, 213130, https:\/\/doi.org\/10.1155\/2013\/213130 (2013).","journal-title":"Mediators Inflamm."},{"key":"58039_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jep.2016.03.026","volume":"185","author":"CF Wang","year":"2016","unstructured":"Wang, C. F. et al. Protection of tauroursodeoxycholic acid on high glucose-induced human retinal microvascular endothelial cells dysfunction and streptozotocin-induced diabetic retinopathy rats. J. Ethnopharmacol. 185, 162\u2013170, https:\/\/doi.org\/10.1016\/j.jep.2016.03.026 (2016).","journal-title":"J. Ethnopharmacol."},{"key":"58039_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00281-008-0111-x","volume":"30","author":"AP Adamis","year":"2008","unstructured":"Adamis, A. P. & Berman, A. J. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin. Immunopathol. 30, 65\u201384, https:\/\/doi.org\/10.1007\/s00281-008-0111-x (2008).","journal-title":"Semin. Immunopathol."},{"key":"58039_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/jop.2010.0012","volume":"26","author":"SJ Woo","year":"2010","unstructured":"Woo, S. J., Kim, J. H. & Yu, H. G. Ursodeoxycholic acid and tauroursodeoxycholic acid suppress choroidal neovascularization in a laser-treated rat model. J. Ocul. Pharmacol. Ther. 26, 223\u2013229, https:\/\/doi.org\/10.1089\/jop.2010.0012 (2010).","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"58039_CR31","doi-asserted-by":"publisher","unstructured":"Liu, Y. et al. Reversible retinal vessel closure from VEGF-induced leukocyte plugging. JCI Insight 2, https:\/\/doi.org\/10.1172\/jci.insight.95530 (2017).","DOI":"10.1172\/jci.insight.95530"},{"key":"58039_CR32","doi-asserted-by":"publisher","first-page":"6126","DOI":"10.1523\/JNEUROSCI.0322-12.2012","volume":"32","author":"Y Omori","year":"2012","unstructured":"Omori, Y. et al. Presynaptic dystroglycan-pikachurin complex regulates the proper synaptic connection between retinal photoreceptor and bipolar cells. J. Neurosci. 32, 6126\u20136137, https:\/\/doi.org\/10.1523\/JNEUROSCI.0322-12.2012 (2012).","journal-title":"J. Neurosci."},{"key":"58039_CR33","unstructured":"Team, R. C. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https:\/\/www.r-project.org\/ (2018)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58039-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58039-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58039-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T05:57:46Z","timestamp":1670306266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58039-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["58039"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-58039-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]},"assertion":[{"value":"5 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"977"}}